Login  |  Register
go Advanced Search

My Cart (0 items) Help

 

Canada (change)

   

HomeMedicine Internal Medicine
 

Antibacterial Therapy and Newer Agents , An Issue of Medical Clinics of North America

Saunders Title
ISBN: 978-1-4557-2291-4

Add to Cart
Check Out

Antibacterial Therapy and Newer Agents , An Issue of Medical Clinics of North America

By Keith S. Kaye, MD, MPH and Donald Kaye, MD, MACP

224 pages
Copyright 2011
$107.99, Hardcover, Reference

A title in the The Clinics: Internal Medicine Series.

Availability:This title is currently out of stock. We will ship as soon as we receive our stock.

 


Description

This issue of Medical Clinics of North America brings the physician up to date on the newest agents for antibacterial therapy.  New drugs are covered, as well as new approaches.  Topics include the newer fluoroquinolones; epidemiology, molecular mechanisms, and clinical management of pathogens resistant to antibacterial agents; current use for old antibacterial agents, including polymyxins, rifamycins, and aminoglycosides; topical antibacterial agents; newer beta-lactam antibiotics, including doripenem, ceftobiprole. ceftaroline, and cefepim; the use of antibacterial agents in renal failure; antibiotics for gram positive bacterial infections, including vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinolones, daptomycin, telavancin, and ceftaroline; as well as macrolides, ketolides, and glycylcyclines, including azithromycin, clarithromycin, telithromycin, and tigecycline.

Author Information

By Keith S. Kaye, MD, MPH, Professor of Internal Medicine and Infectious Diseases Wayne State University School of Medicine Corporate Director of Infection Prevention Hospital Epidemiology and Antimicrobial Stewardship Detroit Medical Center Detroit, MI and Donald Kaye, MD, MACP

Sign up today

Free Shipping with Online Orders

Print this page